No se ha informado de toxicidad sistmica en estudios en humanos o animales
Because TB-500 distributes systemically regardless of injection site, there is no clinical requirement to inject near the injury
Chen LM, Bao CH, Wu Y, Liang SH, Wang D, Wu LY, et al
10.1002/cam4.6865 288 LiuY.ForsytheP
The combination of cabozantinib (anti-c-MET) with durvalumab (anti-PD-L1) can inhibit tumor angiogenesis and modulate the immune microenvironment, demonstrating promising efficacy in MSS CRC patients refractory to chemotherapy [157]
Ingredients: Water, Centella Asiatica Extract, Butylene Glycol, Glycerin, Dipropylene Glycol, Hydroxyethyl Urea, Allantoin, Panthenol, Sodium Hyaluronate, Hydrolyzed Collagen, sh-Oligopeptide-1, Nelumbo Nucifera Germ Extract, Artemisia Annua Extract, Oryza Sativa Extract, Saccharomyces Ferment, Solanum Melongena Fruit Extract, Melaleuca Alternifolia Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Madecassic Acid, Asiaticoside, Asiatic Acid, Trideceth-10, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Citric Acid, Sodium Citrate